Putative Stem Cells and Epithelial-mesenchymal Transition Revealed in Sections of Ovarian Tumor in Patients with Serous Ovarian Carcinoma Using Immunohistochemistry for Vimentin and Pluripotency-related Markers

Overview

Journal J Ovarian Res

Publisher Biomed Central

Specialties Gynecology & Obstetrics
Reproductive Medicine

Date 2017 Feb 25

PMID 28231820

Citations 15

Authors

Natasa Kenda Suster

Spela Smrkolj

Irma Virant-Klun

Affiliations

Soon will be listed here.

Abstract

Background: The mechanism of aggressive character of ovarian cancer and unsuccessful treatment of women with this deadly disease has been recently explained by the theory of cancer stem cells (CSCs). It has been reported that ovarian carcinogenesis and progression of disease is associated with epithelial-mesenchymal transition (EMT). EMT, a physiological cell process during embryonic development and later in life during regeneration, could, when induced in pathological condition, generate CSCs-like cells. Until now EMT in the ovarian tissue has been mainly studied in cell cultures in vitro. The aim of this study was to focus on in situ morphological changes in the ovarian surface epithelium of tumor tissue in women with epithelial ovarian cancer after we applied the antibodies for markers of EMT vimentin and pluripotency-related markers NANOG, SOX2 and SSEA-4.

Methods: We analyzed ovarian tissue sections of 20 women with high grade serous ovarian carcinoma. After eosin and hematoxylin staining, used in standard practice, immunohistochemistry was performed for vimentin and markers of pluripotency: NANOG, SSEA-4 and SOX2. We focused on the ovarian surface epithelium in order to observe morphological changes in tumor tissue.

Results: Among epithelial cells of the ovarian surface epithelium in women with serous ovarian carcinoma we observed a population of small NANOG-positive cells with diameters of up to 5 μm and nuclei, which filled almost the entire cell volumes. These small NANOG-positive cells were in some cases concentrated in the regions with morphologically changed epithelial cells. In these regions, a population of bigger round cells with diameters of 10-15 μm with large nuclei, and positively stained for vimentin, NANOG and other markers of pluripotnecy, were released from the surface epithelium. These cells are proposed as CSCs, and possibly originate from small stem cells among epithelial cells. They formed typical cell clusters, invaded the tissue by changing their round shape into a mesenchymal-like phenotype, and contributed to the manifestation of ovarian cancer.

Conclusions: Our findings show morphological changes in the ovarian surface epithelium in tumor slides of high grade serous ovarian carcinoma and provide a new population of putative CSCs.

Citing Articles

Clinicopathologic Impact of NANOG, ZEB1, and EpCAM Biomarkers on Prognosis of Serous Ovarian Carcinoma.

Ibrahim H, Abdelrahman A, Elsebai E, Gharieb S, Fahmy M, Ramadan M Asian Pac J Cancer Prev. 2023; 24(9):3247-3259.

PMID: 37774079 PMC: 10762767. DOI: 10.31557/APJCP.2023.24.9.3247.

An experimental model for ovarian cancer: propagation of ovarian cancer initiating cells and generation of ovarian cancer organoids.

Chen Y, Lu C, Cheng W, Kuo K, Yu C, Ho H BMC Cancer. 2022; 22(1):967.

PMID: 36085021 PMC: 9463800. DOI: 10.1186/s12885-022-10042-3.

Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention.

Raivola J, Dini A, Karvonen H, Piki E, Salokas K, Niininen W Cell Death Dis. 2022; 13(8):714.

PMID: 35977930 PMC: 9386025. DOI: 10.1038/s41419-022-05161-5.

Female Germ Cell Development, Functioning and Associated Adversities under Unfavorable Circumstances.

Bharti D, Tikka M, Lee S, Bok E, Lee H, Rho G Int J Mol Sci. 2021; 22(4).

PMID: 33671303 PMC: 7922109. DOI: 10.3390/ijms22041979.

Laminin‑332 mediates proliferation, apoptosis, invasion, migration and epithelial‑to‑mesenchymal transition in pancreatic ductal adenocarcinoma.

Huang C, Chen J Mol Med Rep. 2020; 23(1).

PMID: 33179081 PMC: 7673329. DOI: 10.3892/mmr.2020.11649.

References

Davidson B, Holth A, Hellesylt E, Tan T, Huang R, Trope C . The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions. Hum Pathol. 2014; 46(1):1-8. DOI: 10.1016/j.humpath.2014.10.004. View

Virant-Klun I, Zech N, Rozman P, Vogler A, Cvjeticanin B, Klemenc P . Putative stem cells with an embryonic character isolated from the ovarian surface epithelium of women with no naturally present follicles and oocytes. Differentiation. 2008; 76(8):843-56. DOI: 10.1111/j.1432-0436.2008.00268.x. View

Krivtsov A, Twomey D, Feng Z, Stubbs M, Wang Y, Faber J . Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature. 2006; 442(7104):818-22. DOI: 10.1038/nature04980. View

Pan Y, Jiao J, Zhou C, Cheng Q, Hu Y, Chen H . Nanog is highly expressed in ovarian serous cystadenocarcinoma and correlated with clinical stage and pathological grade. Pathobiology. 2011; 77(6):283-8. DOI: 10.1159/000320866. View

Hay E . The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn. 2005; 233(3):706-20. DOI: 10.1002/dvdy.20345. View

Yang J, Weinberg R . Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008; 14(6):818-29. DOI: 10.1016/j.devcel.2008.05.009. View

Massague J . TGFbeta in Cancer. Cell. 2008; 134(2):215-30. PMC: 3512574. DOI: 10.1016/j.cell.2008.07.001. View

Lam S, Mak A, Yam J, Cheung A, Ngan H, Wong A . Targeting estrogen-related receptor alpha inhibits epithelial-to-mesenchymal transition and stem cell properties of ovarian cancer cells. Mol Ther. 2014; 22(4):743-51. PMC: 3982489. DOI: 10.1038/mt.2014.1. View

Ahmed N, Thompson E, Quinn M . Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol. 2007; 213(3):581-8. DOI: 10.1002/jcp.21240. View

10.

Virant-Klun I, Stimpfel M . Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer. Sci Rep. 2016; 6:34730. PMC: 5050448. DOI: 10.1038/srep34730. View

11.

Thiery J, Acloque H, Huang R, Nieto M . Epithelial-mesenchymal transitions in development and disease. Cell. 2009; 139(5):871-90. DOI: 10.1016/j.cell.2009.11.007. View

12.

Kalluri R, Weinberg R . The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6):1420-8. PMC: 2689101. DOI: 10.1172/JCI39104. View

13.

Franci C, Takkunen M, Dave N, Alameda F, Gomez S, Rodriguez R . Expression of Snail protein in tumor-stroma interface. Oncogene. 2006; 25(37):5134-44. DOI: 10.1038/sj.onc.1209519. View

14.

Virant-Klun I, Stimpfel M, Cvjeticanin B, Vrtacnik-Bokal E, Skutella T . Small SSEA-4-positive cells from human ovarian cell cultures: related to embryonic stem cells and germinal lineage?. J Ovarian Res. 2013; 6:24. PMC: 3660272. DOI: 10.1186/1757-2215-6-24. View

15.

Kashyap V, Rezende N, Scotland K, Shaffer S, Persson J, Gudas L . Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev. 2009; 18(7):1093-108. PMC: 3135180. DOI: 10.1089/scd.2009.0113. View

16.

Zuba-Surma E, Klich I, Greco N, Laughlin M, Ratajczak J, Ratajczak M . Optimization of isolation and further characterization of umbilical-cord-blood-derived very small embryonic/ epiblast-like stem cells (VSELs). Eur J Haematol. 2009; 84(1):34-46. DOI: 10.1111/j.1600-0609.2009.01352.x. View

17.

Jiang H, Lin X, Liu Y, Gong W, Ma X, Yu Y . Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment. Mol Med. 2012; 18:1197-208. PMC: 3510297. DOI: 10.2119/molmed.2012.00075. View

18.

Ye F, Li Y, Hu Y, Zhou C, Hu Y, Chen H . Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma. Int J Gynecol Cancer. 2010; 20(6):958-64. DOI: 10.1111/IGC.0b013e3181e6fee1. View

19.

Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S . Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 2003; 113(5):643-55. DOI: 10.1016/s0092-8674(03)00392-1. View

20.

Hollier B, Evans K, Mani S . The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies. J Mammary Gland Biol Neoplasia. 2009; 14(1):29-43. DOI: 10.1007/s10911-009-9110-3. View